GTBPVSUROY• 28 Days (Normalized)
GTBP vs UROY (GT Biopharma Inc. vs Uranium Royalty Corp.)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+2431.12%
GT Biopharma Inc.
Normalized Baseline0.00%
UROY Performance $3.97
-10.59%
Uranium Royalty Corp.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+2441.71 pts
GTBP outperforming by 2441.71 percentage points
GTBPUROY
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP UROY
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | GTBP Price | GTBP Gain (%) | UROY Price | UROY Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +2431.12% | $3.97 | -10.59% | +2441.71% |
| Sep 29, 2026 | $6.88 | +2752.70% | $- | - | |
| Sep 28, 2026 | $6.80 | +2721.58% | $4.00 | -9.91% | +2731.49% |
| Sep 25, 2026 | $6.89 | +2758.92% | $4.14 | -6.76% | +2765.68% |
| Sep 24, 2026 | $6.83 | +2734.02% | $4.25 | -4.28% | +2738.30% |
| Sep 23, 2026 | $7.10 | +2846.06% | $4.42 | -0.45% | +2846.51% |
| Sep 22, 2026 | $- | $4.51 | +1.58% | - | |
| Sep 21, 2026 | $7.18 | +2879.25% | $4.24 | -4.50% | +2883.75% |
| Sep 18, 2026 | $7.16 | +2870.95% | $4.56 | +2.70% | +2868.25% |
| Sep 17, 2026 | $7.49 | +3007.88% | $4.48 | +0.90% | +3006.98% |
| Sep 16, 2026 | $7.81 | +3140.66% | $4.39 | -1.13% | +3141.79% |
| Sep 15, 2026 | $9.00 | +3634.44% | $4.28 | -3.60% | +3638.04% |
| Sep 14, 2026 | $11.63 | +4725.73% | $4.24 | -4.50% | +4730.23% |
| Sep 11, 2026 | $8.61 | +3472.61% | $4.36 | -1.91% | +3474.52% |
| Sep 10, 2026 | $6.18 | +2464.32% | $4.50 | +1.35% | +2462.97% |
Page 1 of 2